GS 9191Alternative Names: GS-9191
Latest Information Update: 15 Dec 2011
At a glance
- Originator Gilead Sciences
- Class Antivirals
- Mechanism of Action DNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Human papillomavirus infections